CMPOV — CompoSecure Income Statement
0.000.00%
- $1.64bn
- $1.91bn
- $390.63m
- 77
- 65
- 25
- 56
Annual income statement for CompoSecure, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 268 | 378 | 391 |
Cost of Revenue | |||
Gross Profit | 145 | 220 | 209 |
Selling / General / Administrative Expenses | |||
Total Operating Expenses | 187 | 264 | 272 |
Operating Profit | 81.4 | 115 | 119 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 82.6 | 136 | 117 |
Provision for Income Taxes | |||
Net Income After Taxes | 83.4 | 132 | 113 |
Minority Interest | |||
Net Income Before Extraordinary Items | |||
Net Income | 13.5 | 18.7 | 19.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Dilution Adjustment | |||
Diluted Net Income | 13.5 | 18.7 | 34.1 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 0.142 | 0.573 | 0.965 |